Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

13.43

-0.77 (-5.42%)

At close: May 18, 2026, 4:00 PM EDT

13.01

-0.42 (-3.13%)

Pre-market: May 19, 2026, 7:00 AM EDT

Trevi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.41	18.91	34.1	32.4	12.59	36.83
Short-Term Investments	152.37	169.35	73.53	50.57	107.92	-
Cash & Short-Term Investments	171.78	188.26	107.62	82.97	120.51	36.83
Cash Growth	66.36%	74.93%	29.71%	-31.15%	227.21%	-18.16%
Other Current Assets	4.34	3.4	1.81	4.58	2.11	1.13
Total Current Assets	176.12	191.66	109.43	87.55	122.62	37.96
Net Property, Plant & Equipment	0.88	0.86	1.23	1.56	0.19	0.18
Other Long-Term Assets	2.61	0.93	0.24	0.3	0.21	0.33
Total Assets	179.61	193.44	110.9	89.4	123.02	38.48
Accounts Payable	2.22	3.91	3.41	1.81	2.86	2.85
Accrued Expenses	4.58	5.53	6.81	3.71	3.52	3.81
Current Portion of Long-Term Debt	-	-	-	-	7	5.83
Current Portion of Leases	0.32	0.31	0.29	0.31	0.03	0.12
Other Current Liabilities	-	-	-	-	-	0.11
Total Current Liabilities	7.12	9.75	10.51	5.82	13.4	12.72
Long-Term Debt	-	-	-	-	2.15	8.65
Long-Term Leases	0.36	0.45	0.75	1.03	0	0.02
Other Long-Term Liabilities	-	-	-	-	0	-
Total Long-Term Liabilities	0.36	0.45	0.75	1.03	2.16	8.68
Total Liabilities	7.48	10.2	11.26	6.86	15.56	21.4
Common Stock	0.13	0.13	0.09	0.07	0.06	0.03
Additional Paid-in Capital	515.19	512.77	386.53	321.64	317.59	197.96
Accumulated Other Comprehensive Income	-0.19	0.15	0.06	-0.03	-0.12	-
Retained Earnings	-343	-329.8	-287.05	-239.13	-210.07	-180.92
Shareholders' Equity	172.13	183.24	99.64	82.55	107.46	17.08
Total Liabilities & Equity	179.61	193.44	110.9	89.4	123.02	38.48
Total Debt	0.68	0.75	1.03	1.34	9.18	14.63
Net Cash (Debt)	171.1	187.51	106.59	81.63	111.33	22.2
Net Cash Growth	-8.75%	75.91%	30.57%	-26.68%	401.47%	-27.89%
Net Cash Per Share	1.21	1.39	1.04	0.82	1.73	0.97
Book Value	172.13	183.24	99.64	82.55	107.46	17.08
Book Value Per Share	1.22	1.36	0.98	0.83	1.66	0.75
Tangible Book Value	172.13	183.24	99.64	82.55	107.46	17.08
Tangible Book Value Per Share	1.22	1.36	0.98	0.83	1.66	0.75

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q